Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharma crawled time : 20:00 save search
Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings
Published: 2024-04-18 (Crawled : 20:00) - globenewswire.com
LUMO | $2.57 -1.91% -1.95% 12K
|
Health Technology
|
| O: 5.16%
H: 6.79%
C: -2.26%
pharma presentation for medical
HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-16 (Crawled : 20:00) - globenewswire.com
HOOK | $0.7317 -4.34% -4.54% 420K
|
Health Technology
|
| O: 0.01%
H: 1.23%
C: -6.17%
award pharma nasdaq grant
Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
Published: 2024-03-29 (Crawled : 20:00) - globenewswire.com
VINC | $0.8475 -5.83% -6.19% 350K
|
| Email alert
Add to watchlist
pharma year update financial results
Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D’Onofrio to Chief Executive Officer
Published: 2024-03-21 (Crawled : 20:00) - globenewswire.com
EVOK | $0.493 2.97% 2.88% 1.9K
|
Health Technology
|
| O: 0.83%
H: 4.45%
C: 1.19%
pharma
aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
Published: 2024-03-14 (Crawled : 20:00) - globenewswire.com
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: 0.0%
H: 24.07%
C: 22.84%
pharma year update results
Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-14 (Crawled : 20:00) - globenewswire.com
EVOK | $0.493 2.97% 2.88% 1.9K
|
Health Technology
|
| O: -4.68%
H: 5.88%
C: -3.58%
pharma year financial results
ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium
Published: 2024-01-25 (Crawled : 20:00) - biospace.com/
EPIX | $6.57 -2.23% -2.28% 100K
|
Health Technology
|
| O: 0.46%
H: 3.06%
C: -22.99%
epi-7386 pharma symposium asco
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-11-03 (Crawled : 20:00) - globenewswire.com
INZY | $4.5 -1.75% -1.78% 590K
|
Health Technology
| Email alert
Add to watchlist
pharma nasdaq grants
HOOKIPA Pharma to Report Third Quarter 2023 Financial Results and Recent Business Highlights on November 9, 2023
Published: 2023-11-02 (Crawled : 20:00) - globenewswire.com
HOOK | $0.7317 -4.34% -4.54% 420K
|
Health Technology
|
| O: 2.33%
H: 13.05%
C: 4.73%
pharma report business financial
Zealand Pharma major shareholder announcement: Polar Capital
Published: 2023-10-20 (Crawled : 20:00) - globenewswire.com
ZEAL | News | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma
Royalty Pharma Declares Fourth Quarter 2023 Dividend
Published: 2023-10-16 (Crawled : 20:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.61%
H: 0.0%
C: 0.0%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: -0.11%
H: 2.08%
C: 1.97%
pharma royalty
Ascendis Pharma Presents TransCon™ PTH (palopegteriparatide) Phase 3 52-Week Skeletal Dynamics Data at ASBMR 2023
Published: 2023-10-16 (Crawled : 20:00) - globenewswire.com
ASND | $140.19 -0.5% -0.5% 270K
|
Health Technology
|
| O: 0.0%
H: 2.02%
C: 0.46%
pharma
Royalty Pharma To Announce Third Quarter 2023 Financial Results On November 8, 2023
Published: 2023-10-11 (Crawled : 20:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.87%
H: 0.0%
C: 0.0%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: 0.15%
H: 0.22%
C: -0.29%
pharma royalty financial results
Athira Pharma Presents Preclinical Data Further Supporting the Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS)
Published: 2023-10-05 (Crawled : 20:00) - globenewswire.com
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: -0.56%
H: 6.15%
C: 5.59%
ath-1105 pharma sclerosis preclinical potential
60 Degrees Pharma Withdraws COVID Phase IIB IND, Will Resubmit Pending Assessment of Ability to Meet FDA Requirements
Published: 2023-09-18 (Crawled : 20:00) - globenewswire.com
SXTP | $0.245 -0.57% -0.57% 92K
|
n/a
|
| O: -26.39%
H: 9.41%
C: 1.24%
fda pharma covid
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Published: 2023-09-14 (Crawled : 20:00) - globenewswire.com
ZEAL | News | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
Published: 2023-09-14 (Crawled : 20:00) - globenewswire.com
ZEAL | News | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma employee
HeartSciences Named Electrocardiography Advancement Specialists of the Year 2023 - USA in the Global Health & Pharma Excellence Awards
Published: 2023-09-11 (Crawled : 20:00) - globenewswire.com
HSCS | $0.101 -6.91% -7.43% 1.1M
|
n/a
|
| O: 2.56%
H: 0.0%
C: -0.01%
pharma health year awards global usa
Ascendis Pharma Reports Second Quarter 2023 Financial Results
Published: 2023-09-05 (Crawled : 20:00) - globenewswire.com
ASND | $140.19 -0.5% -0.5% 270K
|
Health Technology
|
| O: 3.69%
H: 2.93%
C: 0.53%
pharma financial results
Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement
Published: 2023-09-05 (Crawled : 20:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: 0.41%
H: 0.07%
C: -1.86%
ASND | $140.19 -0.5% -0.5% 270K
|
Health Technology
|
| O: 3.69%
H: 2.93%
C: 0.53%
pharma royalty funding agreement
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.